表紙
市場調査レポート

自己免疫疾患における被験者募集:治験当たりの平均被験者数は過去10年で減少を続けている

Clinical Trial Recruitment in Autoimmune Disorders-Average Patient Recruitment Per Trial has Continued to Decline Over the Past Decade

発行 GBI Research 商品コード 212664
出版日 ページ情報 英文 95 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
自己免疫疾患における被験者募集:治験当たりの平均被験者数は過去10年で減少を続けている Clinical Trial Recruitment in Autoimmune Disorders-Average Patient Recruitment Per Trial has Continued to Decline Over the Past Decade
出版日: 2011年09月01日 ページ情報: 英文 95 Pages
概要

多発性硬化症、関節リウマチ、クローン病、潰瘍性大腸炎、乾癬といった自己免疫疾患の主要な5つの適応において、過去10年で治験当たりの平均被験者数が減少を続けています。2000年には408名であったものが、2009年には74名に減少しました。

当レポートでは、自己免疫疾患のための治験動向について調査分析し、治験概要、被験者募集概要とともに、上記の5つの適応別の動向、ブラジル、中国、インドにおける動向などをまとめ、概略以下の構成でお届けします。

第1章 目次

第2章 自己免疫疾患における被験者募集:イントロダクション

第3章 概要

  • 治験デザインが被験者募集に及ぼす影響
    • 治験デザインの種類
  • 被験者募集と参加における現在の課題
    • 厳しい組入れ基準と除外基準
    • ボランティア見通し

第4章 概要

  • 治療分野別治験シェア
  • 自己免疫疾患の5つの適応における治験
  • 自己免疫疾患の5つの適応における被験者募集
  • 自己免疫疾患の主な適応

第5章 多発性硬化症の治験と被験者募集

  • 概要
  • 治験
  • 被験者募集
    • 開発段階別
    • 治験依頼者別
    • 地域別
    • 年度別
  • 治験当たりの平均被験者数
    • 開発段階別
    • 年度別
  • ブラジル、中国、インドにおける有病人口
    • ブラジル
    • 中国
    • インド

第6章 関節リウマチの治験と被験者募集

  • 概要
  • 治験
  • 被験者募集
    • 開発段階別
    • 治験依頼者別
    • 地域別
    • 年度別
  • 治験当たりの平均被験者数
    • 開発段階別
    • 年度別
  • ブラジル、中国、インドにおける有病人口
    • ブラジル
    • 中国
    • インド

第7章 クローン病の治験と被験者募集

  • 概要
  • 治験
  • 被験者募集
    • 開発段階別
    • 治験依頼者別
    • 地域別
    • 年度別
  • 治験当たりの平均被験者数
    • 開発段階別
    • 年度別
  • ブラジル、中国、インドにおける有病人口
    • ブラジル
    • 中国
    • インド

第8章 潰瘍性大腸炎の治験と被験者募集

  • 概要
  • 治験
  • 被験者募集
    • 開発段階別
    • 治験依頼者別
    • 地域別
    • 年度別
  • 治験当たりの平均被験者数
    • 開発段階別
    • 年度別
  • ブラジル、中国、インドにおける有病人口
    • ブラジル
    • 中国
    • インド

第9章 乾癬の治験と被験者募集

  • 概要
  • 治験
  • 被験者募集
    • 開発段階別
    • 治験依頼者別
    • 地域別
    • 年度別
  • 治験当たりの平均被験者数
    • 開発段階別
    • 年度別
  • ブラジル、中国、インドにおける有病人口
    • ブラジル
    • 中国
    • インド
  • 第10章 付録

図表

目次
Product Code: GBIHC118MR

Abstract

Summary

GBI Research, the leading business intelligence provider, has released its latest research “Clinical Trial Recruitment in Autoimmune Disorders-Average Patient Recruitment per Trial has Continued to Decline Over the Past Decade” which provides an insight into clinical trial and patient recruitment in Autoimmune Disorders. The report examines different aspects concerning clinical trial and patient recruitment. The report analyzes the number of clinical trials and the number of patients recruited for five major indications such as Multiple Sclerosis, Rheumatoid Arthritis, Crohn's Disease, Ulcerative Colitis and Psoriasis. It provides information about the total number of clinical trials conducted, by stage of development, geography, major sponsors and trails conducted per year. Analysis on the total number of patients recruited and the average number of patients recruited per each trial is also provided. The report analyzes the total number of patients recruited by stage of development, geography, major sponsors and trails conducted per year from 2000 to 2009. The average number of patients recruited by stage of development per year is also covered. For Brazil, China and India, an estimate of the prevalence population has also been provided for the years 2010 to 2017 across the five major Autoimmune Disorders.

Autoimmune Disorders represent a collective group of disorders which primarily arise due to an overactive immune response of the body against substances and tissues normally present within the body. Major clinical trial recruitment is conducted for Rheumatoid Arthritis. The numbers of clinical trials and patients recruited for this disease are 230 and 19,087 respectively. The average number of patients recruited per trial is highest for Rheumatoid Arthritis when compared to that of other indications.

Scope

  • The report covers clinical trials, patient recruitment, average patient recruitment and prevalence population estimation for five major autoimmune disorders. The prevalence estimates is done for countries such as Brazil, India and China.
  • The report covers different types of study designs and challenges faced in clinical trial recruitment as a whole.
  • Status of Clinical Trials: It covers clinical trials for five major indications by stage of development, by sponsor, by geography and clinical trials conducted per year.
  • Status of Patient Recruitment: It includes patient recruitment for five major indications by stage of development, by sponsor, by geography and clinical trials conducted per year. The report emphasizes on the average number of patients recruited per trial by stage of development and by year.
  • Prevalence Population Estimation: The estimation for the years 2010 to 2017 gives an idea about the prevalence of the five major indications in the future.

Reasons to buy

The report will assist business development and marketing executives to strategize their product launches, by allowing them to:

  • Develop a better study design for better patient recruitment.
  • Plan an effective clinical trial recruitment management by understanding the trend of clinical trials and patient recruitment conducted for five major Autoimmune Disorders for the period 2000 to 2009
  • Understand the clinical trial trend across the globe for major indications in Autoimmune Disorders which covers an in-depth analysis on clinical trials by Phase, by sponsor, by geography and by year.
  • Understand the trend of patient recruitment across the globe for major indications in Autoimmune Disorders which covers an in-depth analysis on patient recruitment by Phase, by sponsor, by geography and by year.
  • Know the top companies that conducted highest clinical trial recruitment by indication and Develop key strategic initiatives by studying the key strategies of top competitors
  • Know the clinical trial recruitment share in autoimmune Disorders across the globe.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Clinical Trial Recruitment in Autoimmune Disorders- Introduction

  • 2.1. GBI Report Guidance

3. Clinical Trail and Patient Recruitment- Overview

  • 3.1. Effect of Clinical Trial Study Design on Patient Recruitment
    • 3.1.1. Types of Study Designs
  • 3.2. Current Challenges in Clinical Trial Recruitment and Enrollment
    • 3.2.1. Challenges in Clinical Trials Due to Stringent Inclusive & Exclusive Criteria
    • 3.2.2. Challenges in Clinical Research- Volunteer Perspective

4. Clinical Trial Recruitment in Autoimmune Disorders- Overview

  • 4.1. Clinical Trial Share by Therapeutic Area
  • 4.2. Clinical Trials for the Five Major Indications in Autoimmune Disorders
  • 4.3. Patient Recruitment for the Five Major Indications in Autoimmune Disorders
  • 4.4. Major Indications in Autoimmune Disorders

5. Clinical Trials and Patient Recruitment for Multiple Sclerosis

  • 5.1. Multiple Sclerosis- Overview
  • 5.2. Clinical Trials for Multiple Sclerosis
    • 5.2.1. Number of Clinical Trials by Stage of Development
    • 5.2.2. Number of Clinical Trials by Sponsor
    • 5.2.3. Number of Clinical Trials by Geography
    • 5.2.4. Number of Clinical Trials per Year
  • 5.3. Patient Recruitment for Multiple Sclerosis
    • 5.3.1. Number of Patients Recruited by Stage of Development
    • 5.3.2. Number of Patients Recruited by Sponsor
    • 5.3.3. Number of Patients Recruited by Geography
    • 5.3.4. Number of Patients Recruited per Year
  • 5.4. Average Number of Patients Recruited per Trial
    • 5.4.1. Average Number of Patients Recruited per Trial by Stage of Development
    • 5.4.2. Average Number of Patients Recruited per Trial per Year
  • 5.5. Prevalence Population for Multiple Sclerosis in Brazil, China and India
    • 5.5.1. Prevalence Population for Multiple Sclerosis in Brazil (2010-2017)
    • 5.5.2. Prevalence Population for Multiple Sclerosis in China (2010-2017)
    • 5.5.3. Prevalence Population for Multiple Sclerosis India (2010-2017)

6. Clinical Trials and Patient Recruitment for Rheumatoid Arthritis

  • 6.1. Rheumatoid Arthritis- Overview
  • 6.2. Clinical Trials for Rheumatoid Arthritis
    • 6.2.1. Number of Clinical Trials by Stage of Development
    • 6.2.2. Number of Clinical Trials by Sponsor
    • 6.2.3. Number of Clinical Trials by Geography
    • 6.2.4. Number of Clinical Trials by Year
  • 6.3. Patient Recruitment for Rheumatoid Arthritis
    • 6.3.1. Number of Patients Recruited by Stage of Development
    • 6.3.2. Number of Patients Recruited by Sponsor
    • 6.3.3. Number of Patients Recruited by Geography
    • 6.3.4. Number of Patients Recruited by Year
  • 6.4. Average Number of Patients Recruited per Trial
    • 6.4.1. Average Number of Patients Recruited per Trial by Stage of Development
    • 6.4.2. Average Number of Patients Recruited per Trial per Year
  • 6.5. Prevalence Population for Rheumatoid Arthritis in Brazil, China and India
    • 6.5.1. Prevalence Population for Rheumatoid Arthritis in Brazil (2010-2017)
    • 6.5.2. Prevalence Population for Rheumatoid Arthritis in China (2010-2017)
    • 6.5.3. Prevalence Population for Rheumatoid Arthritis India (2010-2017)

7. Clinical Trials and Patient Recruitment for Crohn's Disease

  • 7.1. Crohn's Disease- Overview
  • 7.2. Clinical Trials for Crohn's Disease
    • 7.2.1. Number of Clinical Trials by Stage of Development
    • 7.2.2. Number of Clinical Trials by Sponsor
    • 7.2.3. Number of Clinical Trials by Geography
    • 7.2.4. Number of Clinical Trials by Year
  • 7.3. Patient Recruitment for Crohn's Disease
    • 7.3.1. Number of Patients Recruited by Stage of Development
    • 7.3.2. Number of Patients Recruited by Sponsor
    • 7.3.3. Number of Patients Recruited by Geography
    • 7.3.4. Number of Patients Recruited by Year
  • 7.4. Average Number of Patients Recruited per Trial
    • 7.4.1. Average Number of Patients Recruited per Trial by Stage of Development
    • 7.4.2. Average Number of Patients Recruited per Trial per Year
  • 7.5. Prevalence Population for Crohn's Disease in Brazil, China and India
    • 7.5.1. Prevalence Population for Crohn's Disease in Brazil (2010-2017)
    • 7.5.2. Prevalence Population for Crohn's Disease in China (2010-2017)
    • 7.5.3. Prevalence Population for Crohn's Disease India (2010-2017)

8. Clinical Trials and Patient Recruitment for Ulcerative Colitis

  • 8.1. Ulcerative Colitis- Overview
  • 8.2. Clinical Trials for Ulcerative Colitis
    • 8.2.1. Number of Clinical Trials by Stage of Development
    • 8.2.2. Number of Clinical Trials by Sponsor
    • 8.2.3. Number of Clinical Trials by Geography
    • 8.2.4. Number of Clinical Trials by Year
  • 8.3. Patient Recruitment for Ulcerative Colitis
    • 8.3.1. Number of Patients Recruited by Stage of Development
    • 8.3.2. Number of Patients Recruited by Sponsor
    • 8.3.3. Number of Patients Recruited by Geography
    • 8.3.4. Number of Patients Recruited by Year
  • 8.4. Average Number of Patients Recruited per Trial
    • 8.4.1. Average Number of Patients Recruited per Trial by Stage of Development
    • 8.4.2. Average Number of Patients Recruited per Trial per Year
  • 8.5. Prevalence Population for Ulcerative Colitis in Brazil, China and India
    • 8.5.1. Prevalence Population for Ulcerative Colitis in Brazil (2010-2017)
    • 8.5.2. Prevalence Population for Ulcerative Colitis in China (2010-2017)
    • 8.5.3. Prevalence Population for Ulcerative Colitis India (2010-2017)

9. Clinical Trials and Patient Recruitment for Psoriasis

  • 9.1. Psoriasis- Overview
  • 9.2. Clinical Trials for Psoriasis
    • 9.2.1. Number of Clinical Trials by Stage of Development
    • 9.2.2. Number of Clinical Trials by Sponsor
    • 9.2.3. Number of Clinical Trials by Geography
    • 9.2.4. Number of Clinical Trials by Year
  • 9.3. Patient Recruitment for Psoriasis
    • 9.3.1. Number of Patients Recruited by Stage of Development
    • 9.3.2. Number of Patients Recruited by Sponsor
    • 9.3.3. Number of Patients Recruited by Geography
    • 9.3.4. Number of Patients Recruited by Year
  • 9.4. Average Number of Patients Recruited per Trial
    • 9.4.1. Average Number of Patients Recruited per Trial by Stage of Development
    • 9.4.2. Average Number of Patients Recruited per Trial per Year
  • 9.5. Prevalence Population for Psoriasis in Brazil, China and India
    • 9.5.1. Prevalence Population for Psoriasis in Brazil (2010-2017)
    • 9.5.2. Prevalence Population for Psoriasis in China (2010-2017)
    • 9.5.3. Prevalence Population for Psoriasis India (2010-2017)

10. Appendix

  • 10.1. Market Definitions
  • 10.2. Abbreviations
  • 10.3. Research Methodology
    • 10.3.1. Clinical Trials Overview
    • 10.3.2. Number of Clinical Trials
    • 10.3.3. Patient Recruitment Status
    • 10.3.4. Prevalence of Disease in India, China and Brazil (2010-2017)
    • 10.3.5. Primary Research
    • 10.3.6. Expert Panel Validation
  • 10.4. Contact Us
  • 10.5. Disclaimer
  • 10.6. Sources

List of Tables

  • Table 1: Clinical Trial Recruitment in Autoimmune Disorders, Global, Total Number of Clinical Trials by Therapeutic Area, 2000-2009
  • Table 2: Clinical Trial Recruitment in Autoimmune Disorders, Total Number of Clinical Trials for Major Indications, 2000-2009
  • Table 3: Clinical Trial Recruitment in Autoimmune Disorders, Total Number of Patients Recruited for 5 Major Indications, 2000-2009
  • Table 4: Clinical Trial Recruitment in Autoimmune Disorders, Number of Pipeline products in Phase III, 2010
  • Table 5: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Clinical Trials by Stage of Development , 2000-2009
  • Table 6: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Clinical Trials by Major Sponsors, 2000-2009
  • Table 7: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Clinical Trials by Geography, 2000-2009
  • Table 8: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Clinical Trials per Year, 2001-2009
  • Table 9: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Patients Recruited by Stage of Development, 2000-2009
  • Table 10: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Patients Recruited by Major Sponsors, 2000-2009
  • Table 11: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Patients Recruited by Geography, 2000-2009
  • Table 12: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Patients Recruited per Year, 2001-2009
  • Table 13: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Average Number of Patients Recruited per Trial by Stage of Development, 2000-2009
  • Table 14: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Average Number of Patients Recruited per Trial per Year, 2001-2009
  • Table 15: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Prevalence Population (in Thousands), Brazil, 2010-2017
  • Table 16: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Prevalence Population (in Thousands), China, 2010-2017
  • Table 17: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Prevalence Population (in Thousands), India, 2010-2017
  • Table 18: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Clinical Trials by Stage of Development, 2000-2009
  • Table 19: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Clinical Trials by Major Sponsors, 2000-2009
  • Table 20: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Clinical Trials by Geography, 2000-2009
  • Table 21: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Clinical Trials per Year, 2000-2009
  • Table 22: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Patients Recruited by Stage of Development, 2000-2009
  • Table 23: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Patients Recruited by Major Sponsors, 2000-2009
  • Table 24: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Patients Recruited by Geography, 2000-2009
  • Table 25: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Patients Recruited per Year, 2000-2009
  • Table 26: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Average Number of Patients Recruited per Trial by Stage of Development, 2000-2009
  • Table 27: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Average Number of Patients Recruited per Trial per Year, 2000-2009
  • Table 28: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Prevalence Population (in Thousands), Brazil, 2010-2017
  • Table 29: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Prevalence Population (in Thousands), China, 2010-2017
  • Table 30: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Prevalence Population (in Thousands), India, 2010-2017
  • Table 31: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Clinical Trials by Stage of Development, 2000-2009
  • Table 32: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Clinical Trials by Major Sponsors, 2000-2009
  • Table 33: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Clinical Trials by Geography, 2000-2009
  • Table 34: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Clinical Trials per Year, 2000-2009
  • Table 35: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Patients Recruited by Stage of Development, 2000-2009
  • Table 36: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Patients recruited by Major Sponsors, 2000-2009
  • Table 37: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Patients Recruited by Geography, 2000-2009
  • Table 38: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Patients Recruited per Year, 2000-2009
  • Table 39: Clinical Trial Recruitment in Autoimmune Disorders Crohn's Disease, Average Number of Patients Recruited per Trial by Stage of Development,2000-2009
  • Table 40: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Average Number of Patients Recruited per Trial per Year, 2000-2009
  • Table 41: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Prevalence Population (in Thousands), Brazil, 2010-2017
  • Table 42: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's DiseaseDisorder, Prevalence Population (in Thousands), China, 2010-2017
  • Table 43: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Prevalence Population (in Thousands), India, 2010-2017
  • Table 44: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Total Number of Clinical Trials by Stage of Development, 2000-2009
  • Table 45: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Total Number of Clinical Trials by Major Sponsors, 2000-2009
  • Table 46: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Total Number of Clinical Trials by Geography, 2000-2009
  • Table 47: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, , Total Number of Clinical Trials per Year, 2000-2009
  • Table 48: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Total Number of Patients Recruited by Stage of Development, 2000-2009
  • Table 49: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Total Number of Patients Recruited by Major Sponsors, 2000-2009
  • Table 50: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Total Number of Patients Recruited by Geography, 2000-2009
  • Table 51: Clinical Trial Recruitment in Auto Immune Disorders, Ulcerative Colitis, Total Number of Patients Recruited per Year, 2000-2009
  • Table 52: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Average Number of Patients Recruited per Trial by Stage of Development,2000-2009
  • Table 53: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Average Number of Patients Recruited per Trial per Year, 2000-2009
  • Table 54: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Prevalence Population (in Thousands), Brazil, 2010-2017
  • Table 55: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Prevalence Population (in Thousands), China, 2010-2017
  • Table 56: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Prevalence Population (in Thousands), India, 2010-2017
  • Table 57: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Clinical Trials by Stage of Development, 2000-2009
  • Table 58: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Clinical Trials by Major Sponsors, 2000-2009
  • Table 59: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Clinical Trials by Geography, 2000-2009
  • Table 60: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Clinical Trials per Year, 2000-2009
  • Table 61: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Patients Recruited by Stage of Development, 2000-2009
  • Table 62: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Patients Recruited by Major Sponsors, 2000-2009
  • Table 63: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Patients Recruited by Geography, 2000-2009
  • Table 64: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Patients Recruited per Year, 2000-2009
  • Table 65: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Average Number of Patients Recruited per Trial by Stage of Development, 2000-2009
  • Table 66: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Average Number of Patients Recruited per Trial per Year, 2000-2009
  • Table 67: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Prevalence Population (in Thousands), Brazil, 2010-2017
  • Table 68: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Prevalence Population (in Thousands), China, 2010-2017
  • Table 69: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Prevalence Population (in Thousands), India, 2010-2017

List of Figures

  • Figure 1: Clinical Trial Recruitment in Autoimmune Disorders, Global, Total Number of Clinical Trials by Therapeutic Area, 2000-2009
  • Figure 2: Clinical Trial Recruitment in Autoimmune Disorders, Total Number of Clinical Trials for Major Indications, 2000-2009
  • Figure 3: Clinical Trial Recruitment in Autoimmune Disorders, Total Number of Patients Recruited for the 5 Major Indications, 2000-2009
  • Figure 4: Clinical Trial Recruitment in Autoimmune Disorders, Number of Pipeline products in Phase III, 2010
  • Figure 5: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Clinical Trials by Stage of Development, 2000-2009
  • Figure 6: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Clinical Trials by Major Sponsors, 2000-2009
  • Figure 7: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Clinical Trials by Geography, 2000-2009
  • Figure 8: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Clinical Trials per Year, 2001-2009
  • Figure 9: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Patients Recruited by Stage of Development, 2000-2009
  • Figure 10: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Patients Recruited by Major Sponsors, 2000-2009
  • Figure 11: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Patients Recruited by Geography, 2000-2009
  • Figure 12: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Total Number of Patients Recruited per Year, 2001-2009
  • Figure 13: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Average Number of Patients Recruited per Trial by Stage of Development,2000-2009
  • Figure 14: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Average Number of Patients Recruited per Trial per Year, 2001-2009
  • Figure 15: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Prevalence Population (in Thousands), Brazil, 2010-2017
  • Figure 16: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Prevalence Population (in Thousands), China, 2010-2017
  • Figure 17: Clinical Trial Recruitment in Autoimmune Disorders, Multiple Sclerosis, Prevalence Population (in Thousands), India, 2010-2017
  • Figure 18: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Clinical Trials by Stage of Development, 2000-2009
  • Figure 19: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Clinical Trials by Major Sponsors, 2000-2009
  • Figure 20: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Clinical Trials by Geography, 2000-2009
  • Figure 21: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Clinical Trials per Year, 2000-2009
  • Figure 22: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Patients Recruited by Stage of Development, 2000-2009
  • Figure 23: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Patients Recruited by Major Sponsors, 2000-2009
  • Figure 24: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Patients Recruited by Geography, 2000-2009
  • Figure 25: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Total Number of Patients Recruited per Year, 2000-2009
  • Figure 26: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Average Number of Patients Recruited per Trial by Stage of Development, 2000-2009
  • Figure 27: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Average Number of Patients Recruited per Trial per Year, 2000-2009
  • Figure 28: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Prevalence Population (in Thousands), Brazil, 2010-2017
  • Figure 29: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Prevalence Population (in Thousands), China, 2010-2017
  • Figure 30: Clinical Trial Recruitment in Autoimmune Disorders, Rheumatoid Arthritis, Prevalence Population (in Thousands), India, 2010-2017
  • Figure 31: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Clinical Trials by Stage of Development, 2000-2009
  • Figure 32: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Clinical Trials by Major Sponsors, 2000-2009
  • Figure 33: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Clinical Trials by Geography, 2000-2009
  • Figure 34: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Clinical Trials per Year, 2000-2009
  • Figure 35: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Patients Recruited by Stage of Development, 2000-2009
  • Figure 36: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Patients recruited by Major Sponsors, 2000-2009
  • Figure 37: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Patients Recruited by Geography, 2000-2009
  • Figure 38: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Total Number of Patients Recruited per Year, 2000-2009
  • Figure 39: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Average Number of Patients Recruited per Trial by Stage of Development,2000-2009
  • Figure 40: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Average Number of Patients Recruited per Trial per Year, 2000-2009
  • Figure 41: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Prevalence Population (in Thousands), Brazil, 2010-2017
  • Figure 42: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Prevalence Population (in Thousands), China, 2010-2017
  • Figure 43: Clinical Trial Recruitment in Autoimmune Disorders, Crohn's Disease, Prevalence Population (in Thousands), India, 2010-2017
  • Figure 44: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Total Number of Clinical Trials by Stage of Development, 2000-2009
  • Figure 45: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Total Number of Clinical Trials by Major Sponsors, 2000-2009
  • Figure 46: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Total Number of Clinical Trials by Geography, 2000-2009
  • Figure 47: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Total Number of Clinical Trials per Year, 2000-2009
  • Figure 48: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Total Number of Patients Recruited by Stage of Development, 2000-2009
  • Figure 49: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Total Number of Patients Recruited by Major Sponsors, 2000-2009
  • Figure 50: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Total Number of Patients Recruited by Geography, 2000-2009
  • Figure 51: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Total Number of Patients Recruited per Year, 2000-2009
  • Figure 52: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Average Number of Patients Recruited per Trial by Stage of Development, 2000-2009
  • Figure 53: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Average Number of Patients Recruited per Trial per Year, 2000-2009
  • Figure 54: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Prevalence Population (in Thousands), Brazil, 2010-2017
  • Figure 55: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Prevalence Population (in Thousands), China, 2010-2017
  • Figure 56: Clinical Trial Recruitment in Autoimmune Disorders, Ulcerative Colitis, Prevalence Population (in Thousands), India, 2010-2017
  • Figure 57: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Clinical Trials by Stage of Development, 2000-2009
  • Figure 58: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Clinical Trials by Major Sponsors, 2000-2009
  • Figure 59: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Clinical Trials by Geography, 2000-2009
  • Figure 60: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Clinical Trials per Year, 2000-2009
  • Figure 61: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Patients Recruited by Stage of Development, 2000-2009
  • Figure 62: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Patients Recruited by Major Sponsors, 2000-2009
  • Figure 63: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Patients Recruited by Geography, 2000-2009
  • Figure 64: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Total Number of Patients Recruited per Year, 2000-2009
  • Figure 65: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Average Number of Patients Recruited per Trial by Stage of Development,2000-2009
  • Figure 66: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Average Number of Patients Recruited per Trial per Year, 2000-2009
  • Figure 67: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Prevalence Population (in Thousands), Brazil, 2010-2017
  • Figure 68: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Prevalence Population (in Thousands), China, 2010-2017
  • Figure 69: Clinical Trial Recruitment in Autoimmune Disorders, Psoriasis, Prevalence Population (in Thousands), India, 2010-2017
Back to Top